Lilia-Celine (Lily) Lozada
Stock Analyst at J.P. Morgan
(1.60)
# 3,598
Out of 4,966 analysts
16
Total ratings
40%
Success rate
0.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lilia-Celine (Lily) Lozada
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Upgraded: Buy | $29 → $32 | $25.55 | +25.24% | 4 | Sep 3, 2026 | |
| ATRC AtriCure | Reiterated: Hold | $36 | $54.54 | -33.99% | 5 | Jul 24, 2026 | |
| XRAY DENTSPLY SIRONA | Reiterated: Hold | n/a | $10.46 | - | 2 | Dec 19, 2025 | |
| TMCI Treace Medical Concepts | Downgraded: Sell | $8 → $5 | $4.51 | +10.86% | 5 | Nov 7, 2025 |
Envista Holdings
Sep 3, 2026
Upgraded: Buy
Price Target: $29 → $32
Current: $25.55
Upside: +25.24%
AtriCure
Jul 24, 2026
Reiterated: Hold
Price Target: $36
Current: $54.54
Upside: -33.99%
DENTSPLY SIRONA
Dec 19, 2025
Reiterated: Hold
Price Target: n/a
Current: $10.46
Upside: -
Treace Medical Concepts
Nov 7, 2025
Downgraded: Sell
Price Target: $8 → $5
Current: $4.51
Upside: +10.86%